Company Filing History:
Years Active: 2022-2024
Title: Pierre Giguere: Innovator in Pharmaceutical Chemistry
Introduction
Pierre Giguere is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of Syk inhibitors. With a total of 2 patents to his name, Giguere's work is recognized for its innovative approach to drug formulation.
Latest Patents
Giguere's latest patents include the crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor. These patents detail the solid forms of the compound and the processes for making these solid forms, along with methods of use. His work emphasizes the importance of characterizing these compounds to enhance their efficacy in therapeutic applications.
Career Highlights
Pierre Giguere is currently employed at Kronos Bio, Inc., where he continues to push the boundaries of pharmaceutical research. His innovative spirit and dedication to advancing drug development have made him a valuable asset to his team and the industry.
Collaborations
Some of Giguere's notable coworkers include Patricia Andres and Peter C Fung. Their collaborative efforts contribute to the dynamic research environment at Kronos Bio, Inc.
Conclusion
Pierre Giguere's contributions to pharmaceutical chemistry through his patents and work at Kronos Bio, Inc. highlight his role as an influential inventor in the field. His innovative approaches to drug formulation continue to pave the way for advancements in medical treatments.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.